| Symbol |
Name |
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 (Langereis blood group)
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABCG5
|
ATP-binding cassette, sub-family G (WHITE), member 5
|
|
ABCG8
|
ATP-binding cassette, sub-family G (WHITE), member 8
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ABO
|
ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)
|
|
ACACA
|
acetyl-CoA carboxylase alpha
|
|
ACACB
|
acetyl-CoA carboxylase beta
|
|
ACKR1
|
atypical chemokine receptor 1 (Duffy blood group)
|
|
ACTN1
|
actinin, alpha 1
|
|
ACTN2
|
actinin, alpha 2
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM18
|
ADAM metallopeptidase domain 18
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFF1
|
AF4/FMR2 family, member 1
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALDH3A1
|
aldehyde dehydrogenase 3 family, member A1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ALMS1
|
Alstrom syndrome protein 1
|
|
AMH
|
anti-Mullerian hormone
|
|
AMIGO2
|
adhesion molecule with Ig-like domain 2
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPTL3
|
angiopoietin-like 3
|
|
ANKH
|
ANKH inorganic pyrophosphate transport regulator
|
|
ANKRD11
|
ankyrin repeat domain 11
|
|
ANO7
|
anoctamin 7
|
|
ANP32A
|
acidic (leucine-rich) nuclear phosphoprotein 32 family, member A
|
|
ANTXR2
|
anthrax toxin receptor 2
|
|
ANXA11
|
annexin A11
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOE
|
apolipoprotein E
|
|
APOH
|
apolipoprotein H (beta-2-glycoprotein I)
|
|
APTX
|
aprataxin
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARG1
|
arginase 1
|
|
ARHGAP31
|
Rho GTPase activating protein 31
|
|
ARHGAP35
|
Rho GTPase activating protein 35
|
|
ARSA
|
arylsulfatase A
|
|
ARX
|
aristaless related homeobox
|
|
ASCL2
|
achaete-scute family bHLH transcription factor 2
|
|
ASL
|
argininosuccinate lyase
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATP10A
|
ATPase, class V, type 10A
|
|
ATP1A2
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide
|
|
ATP6V0C
|
ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c
|
|
ATP8B1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1
|
|
ATXN1
|
ataxin 1
|
|
AVP
|
arginine vasopressin
|
|
AVPR2
|
arginine vasopressin receptor 2
|
|
B2M
|
beta-2-microglobulin
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BCHE
|
butyrylcholinesterase
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BDH2
|
3-hydroxybutyrate dehydrogenase, type 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BICC1
|
BicC family RNA binding protein 1
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BLNK
|
B-cell linker
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP4
|
bone morphogenetic protein 4
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
C4A
|
complement component 4A (Rodgers blood group)
|
|
C4B
|
complement component 4B (Chido blood group)
|
|
C6
|
complement component 6
|
|
CACNA1I
|
calcium channel, voltage-dependent, T type, alpha 1I subunit
|
|
CACNA1S
|
calcium channel, voltage-dependent, L type, alpha 1S subunit
|
|
CALR
|
calreticulin
|
|
CAPN3
|
calpain 3, (p94)
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAST
|
calpastatin
|
|
CAT
|
catalase
|
|
CCL3L1
|
chemokine (C-C motif) ligand 3-like 1
|
|
CCL4L2
|
chemokine (C-C motif) ligand 4-like 2
|
|
CCM2
|
cerebral cavernous malformation 2
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CD247
|
CD247 molecule
|
|
CD28
|
CD28 molecule
|
|
CD36
|
CD36 molecule (thrombospondin receptor)
|
|
CD37
|
CD37 molecule
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD47
|
CD47 molecule
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDC20
|
cell division cycle 20
|
|
CDC25C
|
cell division cycle 25C
|
|
CDC73
|
cell division cycle 73
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDK1
|
cyclin-dependent kinase 1
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CDX2
|
caudal type homeobox 2
|
|
CEBPB
|
CCAAT/enhancer binding protein (C/EBP), beta
|
|
CES1
|
carboxylesterase 1
|
|
CFI
|
complement factor I
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHFR
|
checkpoint with forkhead and ring finger domains, E3 ubiquitin protein ligase
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CHIT1
|
chitinase 1 (chitotriosidase)
|
|
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle)
|
|
CIITA
|
class II, major histocompatibility complex, transactivator
|
|
CLDN16
|
claudin 16
|
|
CNGA3
|
cyclic nucleotide gated channel alpha 3
|
|
CNGB3
|
cyclic nucleotide gated channel beta 3
|
|
COL10A1
|
collagen, type X, alpha 1
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL6A2
|
collagen, type VI, alpha 2
|
|
CRABP2
|
cellular retinoic acid binding protein 2
|
|
CRB1
|
crumbs family member 1, photoreceptor morphogenesis associated
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRYAB
|
crystallin, alpha B
|
|
CRYBB2
|
crystallin, beta B2
|
|
CRYGB
|
crystallin, gamma B
|
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte)
|
|
CSH1
|
chorionic somatomammotropin hormone 1 (placental lactogen)
|
|
CSK
|
c-src tyrosine kinase
|
|
CSRP3
|
cysteine and glycine-rich protein 3 (cardiac LIM protein)
|
|
CST6
|
cystatin E/M
|
|
CTC1
|
CTS telomere maintenance complex component 1
|
|
CTCF
|
CCCTC-binding factor (zinc finger protein)
|
|
CTSC
|
cathepsin C
|
|
CTSK
|
cathepsin K
|
|
CXCL1
|
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11B1
|
cytochrome P450, family 11, subfamily B, polypeptide 1
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C8
|
cytochrome P450, family 2, subfamily C, polypeptide 8
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
DAZ1
|
deleted in azoospermia 1
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCLRE1C
|
DNA cross-link repair 1C
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DDX58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58
|
|
DES
|
desmin
|
|
DFFB
|
DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)
|
|
DHH
|
desert hedgehog
|
|
DHRS2
|
dehydrogenase/reductase (SDR family) member 2
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIRAS3
|
DIRAS family, GTP-binding RAS-like 3
|
|
DMD
|
dystrophin
|
|
DNASE1L3
|
deoxyribonuclease I-like 3
|
|
DPYS
|
dihydropyrimidinase
|
|
DTNA
|
dystrobrevin, alpha
|
|
DYRK1A
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A
|
|
DYSF
|
dysferlin
|
|
EBAG9
|
estrogen receptor binding site associated, antigen, 9
|
|
ECE1
|
endothelin converting enzyme 1
|
|
ECT2
|
epithelial cell transforming 2
|
|
EDEM1
|
ER degradation enhancer, mannosidase alpha-like 1
|
|
EGF
|
epidermal growth factor
|
|
EGFR
|
epidermal growth factor receptor
|
|
EMP3
|
epithelial membrane protein 3
|
|
EPAS1
|
endothelial PAS domain protein 1
|
|
EPB42
|
erythrocyte membrane protein band 4.2
|
|
EPO
|
erythropoietin
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ESPL1
|
extra spindle pole bodies homolog 1 (S. cerevisiae)
|
|
ESR1
|
estrogen receptor 1
|
|
ETS1
|
v-ets avian erythroblastosis virus E26 oncogene homolog 1
|
|
EWSR1
|
EWS RNA-binding protein 1
|
|
EXO1
|
exonuclease 1
|
|
EXOSC10
|
exosome component 10
|
|
EZR
|
ezrin
|
|
F11
|
coagulation factor XI
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FBN1
|
fibrillin 1
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR2C
|
Fc fragment of IgG, low affinity IIc, receptor for (CD32) (gene/pseudogene)
|
|
FGB
|
fibrinogen beta chain
|
|
FGF1
|
fibroblast growth factor 1 (acidic)
|
|
FGF10
|
fibroblast growth factor 10
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR4
|
fibroblast growth factor receptor 4
|
|
FHIT
|
fragile histidine triad
|
|
FLCN
|
folliculin
|
|
FLG
|
filaggrin
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FN1
|
fibronectin 1
|
|
FOXE3
|
forkhead box E3
|
|
FOXL2
|
forkhead box L2
|
|
FOXO1
|
forkhead box O1
|
|
FOXO4
|
forkhead box O4
|
|
FOXP3
|
forkhead box P3
|
|
FPGT
|
fucose-1-phosphate guanylyltransferase
|
|
FRA16D
|
fragile site, aphidicolin type, common, fra(16)(q23.2)
|
|
FREM2
|
FRAS1 related extracellular matrix protein 2
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FURIN
|
furin (paired basic amino acid cleaving enzyme)
|
|
FUT3
|
fucosyltransferase 3 (galactoside 3(4)-L-fucosyltransferase, Lewis blood group)
|
|
FXN
|
frataxin
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GAA
|
glucosidase, alpha; acid
|
|
GABRA4
|
gamma-aminobutyric acid (GABA) A receptor, alpha 4
|
|
GABRR1
|
gamma-aminobutyric acid (GABA) A receptor, rho 1
|
|
GBA
|
glucosidase, beta, acid
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GGTA1P
|
glycoprotein, alpha-galactosyltransferase 1 pseudogene
|
|
GHRHR
|
growth hormone releasing hormone receptor
|
|
GIPR
|
gastric inhibitory polypeptide receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GJB1
|
gap junction protein, beta 1, 32kDa
|
|
GLTP
|
glycolipid transfer protein
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GNAS
|
GNAS complex locus
|
|
GNAT2
|
guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2
|
|
GNRHR
|
gonadotropin-releasing hormone receptor
|
|
GORASP1
|
golgi reassembly stacking protein 1, 65kDa
|
|
GORASP2
|
golgi reassembly stacking protein 2, 55kDa
|
|
GP1BA
|
glycoprotein Ib (platelet), alpha polypeptide
|
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1
|
|
GPR143
|
G protein-coupled receptor 143
|
|
GPR17
|
G protein-coupled receptor 17
|
|
GRK5
|
G protein-coupled receptor kinase 5
|
|
GRN
|
granulin
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTO2
|
glutathione S-transferase omega 2
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HBB
|
hemoglobin, beta
|
|
HCP5
|
HLA complex P5 (non-protein coding)
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMGB2
|
high mobility group box 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HMX1
|
H6 family homeobox 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HOXA9
|
homeobox A9
|
|
HOXB4
|
homeobox B4
|
|
HOXD10
|
homeobox D10
|
|
HP
|
haptoglobin
|
|
HPBP
|
phosphate binding apolipoprotein
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPRT1
|
hypoxanthine phosphoribosyltransferase 1
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
ICAM2
|
intercellular adhesion molecule 2
|
|
ID4
|
inhibitor of DNA binding 4, dominant negative helix-loop-helix protein
|
|
IFIH1
|
interferon induced with helicase C domain 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IL12A
|
interleukin 12A
|
|
IL12RB1
|
interleukin 12 receptor, beta 1
|
|
IL1A
|
interleukin 1, alpha
|
|
IL2
|
interleukin 2
|
|
IL20RA
|
interleukin 20 receptor, alpha
|
|
IL20RB
|
interleukin 20 receptor beta
|
|
IL22RA1
|
interleukin 22 receptor, alpha 1
|
|
IL24
|
interleukin 24
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33
|
interleukin 33
|
|
IL6
|
interleukin 6
|
|
IL7
|
interleukin 7
|
|
INS
|
insulin
|
|
INSL3
|
insulin-like 3 (Leydig cell)
|
|
IRF3
|
interferon regulatory factor 3
|
|
ISG15
|
ISG15 ubiquitin-like modifier
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNQ1
|
potassium channel, voltage gated KQT-like subfamily Q, member 1
|
|
KHDC3L
|
KH domain containing 3-like, subcortical maternal complex member
|
|
KIF21A
|
kinesin family member 21A
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KMT2A
|
lysine (K)-specific methyltransferase 2A
|
|
KRIT1
|
KRIT1, ankyrin repeat containing
|
|
KRT10
|
keratin 10, type I
|
|
KRT39
|
keratin 39, type I
|
|
KRT40
|
keratin 40, type I
|
|
LAG3
|
lymphocyte-activation gene 3
|
|
LAMA2
|
laminin, alpha 2
|
|
LAMA3
|
laminin, alpha 3
|
|
LARS
|
leucyl-tRNA synthetase
|
|
LCAT
|
lecithin-cholesterol acyltransferase
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LGALS7
|
lectin, galactoside-binding, soluble, 7
|
|
LIPC
|
lipase, hepatic
|
|
LIPG
|
lipase, endothelial
|
|
LMNA
|
lamin A/C
|
|
LPL
|
lipoprotein lipase
|
|
LRP1
|
low density lipoprotein receptor-related protein 1
|
|
LRP8
|
low density lipoprotein receptor-related protein 8, apolipoprotein e receptor
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
MAD2L1BP
|
MAD2L1 binding protein
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP3K1
|
mitogen-activated protein kinase kinase kinase 1, E3 ubiquitin protein ligase
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBNL1
|
muscleblind-like splicing regulator 1
|
|
MCAM
|
melanoma cell adhesion molecule
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MED13L
|
mediator complex subunit 13-like
|
|
MEFV
|
Mediterranean fever
|
|
MEOX1
|
mesenchyme homeobox 1
|
|
MGP
|
matrix Gla protein
|
|
MIR151A
|
microRNA 151a
|
|
MIR181B1
|
microRNA 181b-1
|
|
MIR181B2
|
microRNA 181b-2
|
|
MIR192
|
microRNA 192
|
|
MIR20A
|
microRNA 20a
|
|
MIR34A
|
microRNA 34a
|
|
MIR517A
|
microRNA 517a
|
|
MIR517B
|
microRNA 517b
|
|
MIR518B
|
microRNA 518b
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MOV10L1
|
Mov10 RISC complex RNA helicase like 1
|
|
MPO
|
myeloperoxidase
|
|
MRAP
|
melanocortin 2 receptor accessory protein
|
|
MSH2
|
mutS homolog 2
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MT-ND4
|
NADH dehydrogenase, subunit 4 (complex I)
|
|
MT-ND5
|
NADH dehydrogenase, subunit 5 (complex I)
|
|
MT-ND6
|
NADH dehydrogenase, subunit 6 (complex I)
|
|
MT1X
|
metallothionein 1X
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC17
|
mucin 17, cell surface associated
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
MUSK
|
muscle, skeletal, receptor tyrosine kinase
|
|
MVP
|
major vault protein
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYO7A
|
myosin VIIA
|
|
NANOG
|
Nanog homeobox
|
|
NCAM2
|
neural cell adhesion molecule 2
|
|
NDUFS4
|
NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)
|
|
NEDD8
|
neural precursor cell expressed, developmentally down-regulated 8
|
|
NEK8
|
NIMA-related kinase 8
|
|
NF1
|
neurofibromin 1
|
|
NFASC
|
neurofascin
|
|
NFAT5
|
nuclear factor of activated T-cells 5, tonicity-responsive
|
|
NFATC3
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 3
|
|
NFATC4
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NKX2-5
|
NK2 homeobox 5
|
|
NKX6-1
|
NK6 homeobox 1
|
|
NLRP7
|
NLR family, pyrin domain containing 7
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NOX1
|
NADPH oxidase 1
|
|
NPC1
|
Niemann-Pick disease, type C1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NSD1
|
nuclear receptor binding SET domain protein 1
|
|
NYX
|
nyctalopin
|
|
OBSCN
|
obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF
|
|
OCTN3
|
organic cation transporter 3
|
|
OGT
|
O-linked N-acetylglucosamine (GlcNAc) transferase
|
|
OPN1LW
|
opsin 1 (cone pigments), long-wave-sensitive
|
|
ORM1
|
orosomucoid 1
|
|
OXTR
|
oxytocin receptor
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY1
|
purinergic receptor P2Y, G-protein coupled, 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARK7
|
parkinson protein 7
|
|
PAX3
|
paired box 3
|
|
PAX6
|
paired box 6
|
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5
|
|
PCSK7
|
proprotein convertase subtilisin/kexin type 7
|
|
PDCD10
|
programmed cell death 10
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDGFRB
|
platelet-derived growth factor receptor, beta polypeptide
|
|
PDPN
|
podoplanin
|
|
PEBP1
|
phosphatidylethanolamine binding protein 1
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PEX1
|
peroxisomal biogenesis factor 1
|
|
PF4
|
platelet factor 4
|
|
PFKM
|
phosphofructokinase, muscle
|
|
PGR
|
progesterone receptor
|
|
PHOX2B
|
paired-like homeobox 2b
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PIM2
|
Pim-2 proto-oncogene, serine/threonine kinase
|
|
PKLR
|
pyruvate kinase, liver and RBC
|
|
PKM
|
pyruvate kinase, muscle
|
|
PLA2G4C
|
phospholipase A2, group IVC (cytosolic, calcium-independent)
|
|
PLAC1
|
placenta-specific 1
|
|
PLCB1
|
phospholipase C, beta 1 (phosphoinositide-specific)
|
|
PLCB4
|
phospholipase C, beta 4
|
|
PLEKHA3
|
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 3
|
|
PLP1
|
proteolipid protein 1
|
|
PNP
|
purine nucleoside phosphorylase
|
|
POLE
|
polymerase (DNA directed), epsilon, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
POR
|
P450 (cytochrome) oxidoreductase
|
|
POU2AF1
|
POU class 2 associating factor 1
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKCG
|
protein kinase C, gamma
|
|
PRKCI
|
protein kinase C, iota
|
|
PRNP
|
prion protein
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROP1
|
PROP paired-like homeobox 1
|
|
PRSS57
|
protease, serine, 57
|
|
PRTN3
|
proteinase 3
|
|
PSEN1
|
presenilin 1
|
|
PSMA2
|
proteasome (prosome, macropain) subunit, alpha type, 2
|
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
PTCH1
|
patched 1
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PYCARD
|
PYD and CARD domain containing
|
|
RAB27A
|
RAB27A, member RAS oncogene family
|
|
RALBP1
|
ralA binding protein 1
|
|
RAN
|
RAN, member RAS oncogene family
|
|
RB1
|
retinoblastoma 1
|
|
RBMY1A1
|
RNA binding motif protein, Y-linked, family 1, member A1
|
|
RBP3
|
retinol binding protein 3, interstitial
|
|
RECQL5
|
RecQ protein-like 5
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
RETN
|
resistin
|
|
RHD
|
Rh blood group, D antigen
|
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RTN4
|
reticulon 4
|
|
RXFP1
|
relaxin/insulin-like family peptide receptor 1
|
|
RXFP2
|
relaxin/insulin-like family peptide receptor 2
|
|
SCN2A
|
sodium channel, voltage gated, type II alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SDC1
|
syndecan 1
|
|
SELPLG
|
selectin P ligand
|
|
SEN6A
|
senescence (cellular)-related 6A
|
|
SERPINA7
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7
|
|
SERPINB7
|
serpin peptidase inhibitor, clade B (ovalbumin), member 7
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFTPB
|
surfactant protein B
|
|
SGTA
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, alpha
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHOX
|
short stature homeobox
|
|
SLAMF6
|
SLAM family member 6
|
|
SLC15A2
|
solute carrier family 15 (oligopeptide transporter), member 2
|
|
SLC17A5
|
solute carrier family 17 (acidic sugar transporter), member 5
|
|
SLC22A4
|
solute carrier family 22 (organic cation/zwitterion transporter), member 4
|
|
SLC25A4
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 4
|
|
SLC26A4
|
solute carrier family 26 (anion exchanger), member 4
|
|
SLC27A1
|
solute carrier family 27 (fatty acid transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLCO1B1
|
solute carrier organic anion transporter family, member 1B1
|
|
SLCO1B3
|
solute carrier organic anion transporter family, member 1B3
|
|
SMARCB1
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1
|
|
SMUG1
|
single-strand-selective monofunctional uracil-DNA glycosylase 1
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNORD115-1
|
small nucleolar RNA, C/D box 115-1
|
|
SOCS1
|
suppressor of cytokine signaling 1
|
|
SP1
|
Sp1 transcription factor
|
|
SPAST
|
spastin
|
|
SRCAP
|
Snf2-related CREBBP activator protein
|
|
SRD5A2
|
steroid-5-alpha-reductase, alpha polypeptide 2 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 2)
|
|
SRY
|
sex determining region Y
|
|
SSB
|
Sjogren syndrome antigen B (autoantigen La)
|
|
SSTR2
|
somatostatin receptor 2
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT5B
|
signal transducer and activator of transcription 5B
|
|
STK11
|
serine/threonine kinase 11
|
|
STK11IP
|
serine/threonine kinase 11 interacting protein
|
|
STS
|
steroid sulfatase (microsomal), isozyme S
|
|
STX11
|
syntaxin 11
|
|
SUCLG1
|
succinate-CoA ligase, alpha subunit
|
|
SULT2A1
|
sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1
|
|
SUMF1
|
sulfatase modifying factor 1
|
|
TAF7
|
TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa
|
|
TAT
|
tyrosine aminotransferase
|
|
TCEB1
|
transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)
|
|
TCF4
|
transcription factor 4
|
|
TCL1A
|
T-cell leukemia/lymphoma 1A
|
|
TEK
|
TEK tyrosine kinase, endothelial
|
|
TEN1
|
TEN1 CST complex subunit
|
|
TERT
|
telomerase reverse transcriptase
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TFRC
|
transferrin receptor
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR1
|
transforming growth factor, beta receptor 1
|
|
TLR9
|
toll-like receptor 9
|
|
TMEM70
|
transmembrane protein 70
|
|
TNFAIP3
|
tumor necrosis factor, alpha-induced protein 3
|
|
TNFRSF10A
|
tumor necrosis factor receptor superfamily, member 10a
|
|
TNFRSF1B
|
tumor necrosis factor receptor superfamily, member 1B
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNS2
|
tensin 2
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TOP2A
|
topoisomerase (DNA) II alpha 170kDa
|
|
TP53
|
tumor protein p53
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPT1
|
tumor protein, translationally-controlled 1
|
|
TRA
|
T cell receptor alpha locus
|
|
TRPM1
|
transient receptor potential cation channel, subfamily M, member 1
|
|
TSC1
|
tuberous sclerosis 1
|
|
TSC2
|
tuberous sclerosis 2
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TTC19
|
tetratricopeptide repeat domain 19
|
|
TXN
|
thioredoxin
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UGT1A9
|
UDP glucuronosyltransferase 1 family, polypeptide A9
|
|
UMPS
|
uridine monophosphate synthetase
|
|
UNG
|
uracil-DNA glycosylase
|
|
UPB1
|
ureidopropionase, beta
|
|
USH1C
|
Usher syndrome 1C (autosomal recessive, severe)
|
|
USP19
|
ubiquitin specific peptidase 19
|
|
USP26
|
ubiquitin specific peptidase 26
|
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C
|
|
VCAN
|
versican
|
|
VHL
|
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase
|
|
VWF
|
von Willebrand factor
|
|
WNK1
|
WNK lysine deficient protein kinase 1
|
|
WNT7A
|
wingless-type MMTV integration site family, member 7A
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
YES1
|
YES proto-oncogene 1, Src family tyrosine kinase
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZMPSTE24
|
zinc metallopeptidase STE24
|
